Table 3 Adverse events of influenza vaccination in juvenile systemic lupus erythematosus (JSLE) and healthy controls
JSLE (n = 24) | Healthy controls (n = 29) | P | |
|---|---|---|---|
Asymptomatic | 14 (58.3%) | 13 (44.8%) | 0.958 |
Local reactions | |||
Pain | 7 (29) | 8 (28) | 1.000 |
Redness | 2 (8) | 0 (0) | 0.20 |
Swelling | 2 (8) | 1 (3) | 0.584 |
Itching | 0 (0) | 2 (7) | 0.495 |
Systemic reactions | |||
Fever | 2 (8) | 2 (7) | 1.000 |
Malaise | 0 (0) | 1 (3) | 1.000 |
Nausea | 1 (4) | 1 (3) | 1.000 |
Vomit | 1 (4) | 0 (0) | 0.453 |
Diarrhea | 1 (4) | 0 (0) | 0.453 |
Vertigo | 1 (4) | 0 (0) | 0.453 |
Tremor | 0 (0) | 0 (0) | 1.00 |
Headache | 6 (25) | 5 (17) | 0.518 |
Myalgia | 0 (0) | 2 (7) | 0.495 |
Muscle weakness | 0 (0) | 2 (7) | 0.495 |
Arthralgia | 0 (0) | 1 (3) | 1.000 |
Cough | 1 (4) | 5 (17) | 0.204 |
Coryza | 0 (0) | 5 (17) | 0.056 |
Sore throat | 2 (8) | 4 (14) | 0.678 |
Conjunctivitis | 0 (0) | 0 (0) | 1.000 |